1. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene;Boviatsis;Cancer Res.,1994
2. Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase;Boviatsis;Gene Ther.,1994
3. Breakefield, X.O., Jacobs, A. and Wang, S. (1997) Genetic engineering for CNS regeneration. In: Tuszynski, M. (Ed.), CNS Regeneration: Basic Science and Clinical Applications, Vol 4. Academic Press, New York, pp. 1281–1283.
4. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus;Brubaker;J. Immunol.,1996
5. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype;Buller;Nature,1985